Chronic fluoxetine treatment alters cardiovascular functions in unanesthetized rats

European Journal of Pharmacology

Volumn 670, Issue 2-3, 2011, Pages 527-533

  Crestani, Carlos C ^a   Tavares, Rodrigo F ^b   Guimarães, Franscisco S ^b   Correa, Fernando M A ^b   Joca, Sâmia R L ^b   Resstel, Leonardo B M ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Arterial pressure; Baroreflex; Chronic fluoxetine treatment; Heart rate; Hypertension; Psychological stress

Indexed keywords

FLUOXETINE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; BRADYCARDIA; CARDIOVASCULAR FUNCTION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG RESPONSE; HEART RATE; HYPERTENSION; IMMOBILIZATION STRESS; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; TACHYCARDIA;

ANIMALS; BAROREFLEX; BASAL METABOLISM; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; CARDIOVASCULAR SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FLUOXETINE; HEART RATE; NITROPRUSSIDE; PHENYLEPHRINE; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 80755133528     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.09.030     Document Type: Article

References (39)

1. T. Akata Cellular and molecular mechanisms regulating vascular tone. Part 2: regulatory mechanisms modulating Ca2+ mobilization and/or myofilament Ca2+ sensitivity in vascular smooth muscle cells J. Anesth. 21 2007 232 242 (Pubitemid 46692016)
2. R.H. Alper Effects of the selective serotonin reuptake inhibitor fluoxetine on baroreceptor reflex sensitivity and body weight in young and old rats J. Gerontol. 47 1992 B130 B136
3. M. Auguet, F. Clostre, and F.V. DeFeudis Effects of antidepressants on receptor-activated and Ca2+-activated contractions of rabbit isolated aorta Gen. Pharmacol. 17 1986 607 610 (Pubitemid 16025998)
4. C.C. Crestani, F.H. Alves, C. Busnardo, L.B. Resstel, and F.M. Correa N-methyl-D-aspartate glutamate receptors in the hypothalamic paraventricular nucleus modulate cardiac component of the baroreflex in unanesthetized rats Neurosci. Res. 67 2010 317 326
5. R.A. Dampney, J. Horiuchi, and L.M. McDowall Hypothalamic mechanisms coordinating cardiorespiratory function during exercise and defensive behaviour Auton. Neurosci. 142 2008 3 10
6. C.C. Deck, T.E. Raya, M.A. Gaballa, and S. Goldman Baroreflex control of heart rate in rats with heart failure after myocardial infarction: effects of captopril J. Pharmacol. Exp. Ther. 263 1992 1424 1431 (Pubitemid 23157226)
7. M. Durand, O. Berton, S. Aguerre, L. Edno, I. Combourieu, P. Mormede, and F. Chaouloff Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats Neuropharmacology 38 1999 893 907 (Pubitemid 29187349)
8. R.W. Fuller, D.R. Holland, T.T. Yen, K.G. Bemis, and N.B. Stamm Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats Life Sci. 25 1979 1237 1242 (Pubitemid 10190911)
9. D.S. Goldstein Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension Circulation 68 1983 234 240
10. F.J. Gordon, H. Matsuguchi, and A.L. Mark Abnormal baroreflex control of heart rate in prehypertensive and hypertensive Dahl genetically salt-sensitive rats Hypertension 3 1981 I135 I141
11. L. Gram Fluoxetine N. Engl. J. Med. 331 1994 1354 1361 (Pubitemid 24984727)
12. G. Grassi, F.Q. Trevano, G. Seravalle, F. Scopelliti, and G. Mancia Baroreflex function in hypertension: consequences for antihypertensive therapy Prog. Cardiovasc. Dis. 48 2006 407 415 (Pubitemid 44250757)
13. A.J. Grippo, T.G. Beltz, R.M. Weiss, and A.K. Johnson The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia Biol. Psychiatry 59 2006 309 316 (Pubitemid 43238355)
14. D.G. Harrison, P.C. Freiman, M.L. Armstrong, M.L. Marcus, and D.D. Heistad Alterations of vascular reactivity in atherosclerosis Circ. Res. 61 1987 II74 II80
15. G.A. Head, and R. McCarty Vagal and sympathetic components of the heart rate range and gain of the baroreceptor-heart rate reflex in conscious rats J. Auton. Nerv. Syst. 21 1987 203 213 (Pubitemid 18042281)
16. S. Hussein, and B.M. Kaufman Bradycardia associated with fluoxetine in an elderly patient with sick sinus syndrome Postgrad. Med. J. 70 1994 56 (Pubitemid 24050578)
17. M.C. Irigoyen, and E.M. Krieger Baroreflex control of sympathetic activity in experimental hypertension Braz. J. Med. Biol. Res. 31 1998 1213 1220 (Pubitemid 128528228)
18. C. Lino-de-Oliveira, A.J. Sales, E.A. Del Bel, M.C. Silveira, and F.S. Guimaraes Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression Brain Res. Bull. 55 2001 747 754 (Pubitemid 32930077)
19. X. Liu, B.J. Smith, C. Chen, E. Callegari, S.L. Becker, X. Chen, J. Cianfrogna, A.C. Doran, S.D. Doran, J.P. Gibbs, N. Hosea, J. Liu, F.R. Nelson, M.A. Szewc, and J. Van Deusen Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding J. Pharmacol. Exp. Ther. 313 2005 1254 1262 (Pubitemid 40727030)
20. S.J. McDougall, A.J. Lawrence, and R.E. Widdop Differential cardiovascular responses to stressors in hypertensive and normotensive rats Exp. Physiol. 90 2005 141 150
21. J.A. Moffitt, and A.K. Johnson Short-term fluoxetine treatment enhances baroreflex control of sympathetic nervous system activity after hindlimb unloading Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 2004 R584 R590 (Pubitemid 38252625)
22. G. Osculati, G. Grassi, C. Giannattasio, G. Seravalle, F. Valagussa, A. Zanchetti, and G. Mancia Early alterations of the baroreceptor control of heart rate in patients with acute myocardial infarction Circulation 81 1990 939 948 (Pubitemid 20090392)
23. P. Pacher, and V. Kecskemeti Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr. Pharm. Des. 10 2004 2463 2475 (Pubitemid 38997427)
24. P. Pacher, Z. Ungvari, V. Kecskemeti, and A. Koller Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivity Br. J. Pharmacol. 127 1999 740 746 (Pubitemid 29276660)
25. J.A. Panza, P.R. Casino, C.M. Kilcoyne, and A.A. Quyyumi Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension Circulation 87 1993 1468 1474 (Pubitemid 23133089)
26. K.S. Park, I.D. Kong, K.C. Park, and J.W. Lee Fluoxetine inhibits L-type Ca2+ and transient outward K+ currents in rat ventricular myocytes Yonsei Med. J. 40 1999 144 151
27. J.W. Radomski, S.M. Dursun, M.A. Reveley, and S.P. Kutcher An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria Med. Hypotheses 55 2000 218 224
28. T. Ravina, M.L. Suarez, and J. Mendez-Castrillon Fluoxetine-induced QTU interval prolongation, T wave alternans and syncope Int. J. Cardiol. 65 1998 311 313 (Pubitemid 28368340)
29. L.B. Resstel, C.R. Tirapelli, V.L. Lanchote, S.A. Uyemura, A.M. de Oliveira, and F.M. Correa Chronic ethanol consumption alters cardiovascular functions in conscious rats Life Sci. 78 2006 2179 2187
30. L.B. Resstel, F.H. Alves, D.G. Reis, C.C. Crestani, F.M. Correa, and F.S. Guimaraes Anxiolytic-like effects induced by acute reversible inactivation of the bed nucleus of stria terminalis Neuroscience 154 2008 869 876
31. M. Roche, A. Harkin, and J.P. Kelly Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat Neuropsychopharmacology 32 2007 1312 1320 (Pubitemid 46788856)
32. S.P. Roose, A.H. Glassman, E. Attia, S. Woodring, E.G. Giardina, and J.T. Bigger Jr. Cardiovascular effects of fluoxetine in depressed patients with heart disease Am. J. Psychiatry 155 1998 660 665 (Pubitemid 28225407)
33. S.A. Spier, and M.A. Frontera Unexpected deaths in depressed medical inpatients treated with fluoxetine J. Clin. Psychiatry 52 1991 377 382
34. Y.M. Ulrich-Lai, and J.P. Herman Neural regulation of endocrine and autonomic stress responses Nat. Rev. Neurosci. 10 6 2009 397 409
35. Z. Ungvari, P. Pacher, V. Kecskemeti, and A. Koller Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel opener Stroke 30 1999 1949 1954 (Pubitemid 29411840)
36. Z. Ungvari, P. Pacher, and A. Koller Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [Ca2+]i J. Cardiovasc. Pharmacol. 35 2000 849 854 (Pubitemid 30327512)
37. C.E. Van Hove, C. Van der Donckt, A.G. Herman, H. Bult, and P. Fransen Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cells Br. J. Pharmacol. 158 2009 920 930
38. J.M. Vila, P. Medina, G. Segarra, P. Lluch, F. Pallardo, B. Flor, and S. Lluch Relaxant effects of antidepressants on human isolated mesenteric arteries Br. J. Clin. Pharmacol. 48 1999 223 229 (Pubitemid 29349459)
39. D.T. Wong, F.P. Bymaster, L.R. Reid, and P.G. Threlkeld Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors Biochem. Pharmacol. 32 1983 1287 1293 (Pubitemid 13135642)